RECENT PAST NEWS IN MDR-TB

Why is a curable disease allowed to kill millions?

International consensus highlights the importance of molecular testing for MDR-TB

Sweet advance for treatment of children with multi-drug resistant TB

New safer and shorter drug-resistant TB treatment must be scaled up

MSF applauds Indian Patent Office’s rejection of J&J’s attempt to extend patent on lifesaving

World TB Day 2023 Campaign Toolkit

Sutezolid with 3-drug combo appears safe and effective in multidrug-resistant TB

TAG's TB Treatment Pipeline Report Published

Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short

Undernutrition linked to increased mortality in multidrug-resistant TB

Urgent action necessary to improve equitable access to bedaquiline-based regiments and achieve 1/4/6

2022 Updates to Drug-Resistant Tuberculosis: A Survival Guide for Clinicians, 3rd ed.

WHO announces landmark changes in treatment of drug-resistant TB!

Price reduction paves the way for expanded access to highly effective MDR-TB

Public Health Leaders, Researchers, and Activists Launch Campaign to Revolutionize Tuberculosis

New testing method could make TB diagnosis easier

Drug-Resistant TB Trial Results Published in New England Journal of Medicine

MSF warns that supply delays of critical TB test will cost lives

1 / 4 / 6 x 24 Campaign launched to rally energy, political will, funding needed to fight TB

PAN-TB collaboration to advance investigational TB drug regimens to Phase 2 clinical trials